Oncology and Hematology News and Journal Articles
Recent Content
Single patients with soft-tissue sarcoma of the extremities had worse overall survival and were less likely to undergo several important treatment options compared with their married counterparts, according to results of a recent study.
The anti-programmed death 1 (PD-1) drug nivolumab may increase overall survival in patients with advanced melanoma with a safe and acceptable long-term safety profile, according to the results of a recent study.
Besides easing fatigue, yoga also eases pain and depression for women with breast cancer undergoing radiation therapy, a new study finds.
In this interview we discuss the oncogenes driving the development of squamous cell carcinoma of the lung, a type of non-small-cell lung cancer.
The results of a retrospective study indicated that patients with metastatic GIST who are able to achieve complete macroscopic surgical resection of their disease may be able to achieve long-term survival.
The risk for burnout appears to rise in direct proportion to the number of hours oncologists spend on direct patient care, according to a recent survey by ASCO.
Adding dasatinib to standard antihormone therapy letrozole significantly improved the progression-free survival of women with hormone receptor–positive, HER2-negative metastatic breast cancer, according to the results of a small phase II
Major studies looking at breast cancer screening with mammography may have more consistent findings than previously thought.
A year-long exercise program reduced joint pain among breast cancer survivors taking aromatase inhibitors such as anastrozole, letrozole, and exemestane, according to the results of a study presented recently at the 2013 San Antonio Breas
In a 12-patient multiple myeloma pilot study, researchers demonstrated that anti-CD3 and anti-CD20 bispecific antibody (CD20Bi) activated both cellular and humoral anti-myeloma immunity that was detectable after patients received an autologous stem cell transplant.
In this interview we discuss the oncogenes driving the development of squamous cell carcinoma of the lung, a type of non-small-cell lung cancer.
In this interview, we discuss the current state of pancreatic cancer management, and look toward trials to further define the best course of treatment for this deadly disease.
In this interview we discuss prostate cancer highlights from the 2014 ASCO Genitourinary Cancers Symposium.
In this interview we discuss lung cancer prevention, the recent low-dose CT screening recommendations from the USPSTF, hurdles in preventing the disease, and more.
